For citations:
Mudunov A.M., Ignatova A.V., Morozova A.S., Podvyaznikov S.O., Alymov Yu.V. Combination of concurrent targeted and immune-therapy with nivolumab and cetuximab: new perspectives for squamous cell carcinoma treatment. Head and Neck Tumors (HNT). 2020;10(3):111-117. (In Russ.) https://doi.org/10.17650/2222-1468-2020-10-3-111-117
Email this article 